熱門資訊> 正文
Piper Sandler引用估值以中性启动Tempus AI
2024-08-13 01:42
- Piper Sandler has initiated coverage of Tempus AI (NASDAQ:TEM) with a neutral rating, commenting that valuation was keeping it on the sidelines.
- While it sees Tempus as having a “respectable market position in profiling and leading the pack in data and pharma services,” Piper said it would like to see more revenue generation before giving it a top industry multiple.
- “The stock is trading between Natera (NTRA) and Guardant Health (GH), which we think is exactly right, so we think the risk/reward is balanced from here,” Piper said in a note.
- The investment bank set its price target for the stock at $40.
More on Tempus AI
- Earnings Season Launches With Delta, PepsiCo, JPMorgan, And Citi Leading Off
- Tempus AI: Healthcare AI Play Faces Some Challenges From The Start
- Spotlight On Apple's AI Strategy, The Fed Meeting, And Latest CPI Print
- Tempus AI GAAP EPS of -$6.86 misses by $3.53, revenue of $165.97M beats by $5.67M
- Tempus AI down despite bullish starts from analysts
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
